Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia
Authors
Keywords
Klebsiella infections, Death rates, Hospitals, Enterobacteriaceae, Bacteremia, Renal transplantation, Respiratory infections, Blood
Journal
PLoS One
Volume 10, Issue 11, Pages e0143845
Publisher
Public Library of Science (PLoS)
Online
2015-12-01
DOI
10.1371/journal.pone.0143845
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options
- (2013) F. Kontopidou et al. CLINICAL MICROBIOLOGY AND INFECTION
- Correlation of Hospital Carbapenem Consumption and Resistance Trends in Selected Gram-Negative Bacteria
- (2012) Vincent H Tam et al. ANNALS OF PHARMACOTHERAPY
- Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
- (2012) Nan-Yao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
- (2011) D. Ben-David et al. CLINICAL MICROBIOLOGY AND INFECTION
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli or Klebsiella pneumoniae
- (2011) Nan-Yao Lee et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Prevalence and epidemiology of microbial pathogens causing bloodstream infections: results of the OASIS multicenter study
- (2011) Francesco Luzzaro et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Emergence of KPC-producing Klebsiella pneumoniae in Texas
- (2011) Elizabeth B. Hirsch et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients
- (2010) Argyris Michalopoulos et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
- (2010) May Nguyen et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started